Skip to the page

Data / Form D filings / Covariance Labs Inc.

Covariance Labs Inc.: Form D filing

Covariance Labs Inc., a technology company in New York, NY, filed a Form D with the SEC in 2026. The latest, on March 9, 2026, reports $11 million sold of a $11 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1350 AVENUE OF THE AMERICAS, SUITE 1720, New York, NY, 10019
Phone
(914) 721-0835
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2116173

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 9, 2026New notice$10,999,976$10,999,9766Jan 15, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael FlederExecutive Officer, Director
Thomas JermolukDirector

Other technology companies in New York that filed recently

Every Form D from the week of Mar 9, 2026 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Covariance Labs Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.